...
首页> 外文期刊>Cardiovascular revascularization medicine: including molecular interventions >Off-pump coronary artery bypass grafting improves in-hospital mortality in patients with dialysis-dependent renal failure.
【24h】

Off-pump coronary artery bypass grafting improves in-hospital mortality in patients with dialysis-dependent renal failure.

机译:非体外循环冠状动脉搭桥术可改善透析依赖型肾衰竭患者的院内死亡率。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: Patients with chronic dialysis-dependent end-stage renal disease are increasingly referred for coronary artery bypass grafting (CABG) and their early outcome is less favorable. Off-pump CABG (OPCAB) has achieved encouraging results in high-risk patients. Therefore, we designed this retrospective study to test the hypothesis that OPCAB reduced surgical risks in dialysis patients. METHODS: From January 2000 to December 2005, 294 dialysis-dependent patients received isolated CABG at the Washington Hospital Center. Among them, 168 underwent OPCAB (off-pump group), and 126, CABG with cardiopulmonary bypass (CPB) (on-pump group). The in-hospital outcomes were analyzed. RESULTS: The two groups were comparable in terms of preoperative characteristics. The Parsonnet's Bedside Score of the off-pump group was similar to that of the on-pump group (32.0 vs. 32.0, P=.57). The in-hospital mortality of the off-pump group was significantly lower than that of the on-pump group (5.4% vs. 11.9%, P=.04). Although the percentage of patients who received transfusions was similar, the on-pump group received more total transfusions. Logistic regression analysis revealed that use of CPB independently predicted in-hospital mortality [odds ratio (OR), 5.0; 95% confidence interval, 1.78-13.85; P<.01] and perioperative myocardial infarction (MI; OR, 5.1; 95% confidence interval, 1.18-22.40; P=.03). No significant difference in long-term survival at 4 years was absorbed between the two groups of hospital survivors. CONCLUSIONS: Our data suggest that OPCAB is a safe alternative to on-pump CABG in dialysis patients. Avoiding CPB resulted in less perioperative blood utilization, MI, and hospital mortality.
机译:目的:慢性依赖透析的终末期肾脏疾病患者越来越多地接受冠状动脉搭桥术(CABG),其早期结果较差。非泵CABG(OPCAB)在高危患者中取得了令人鼓舞的结果。因此,我们设计了这项回顾性研究,以检验OPCAB降低透析患者手术风险的假设。方法:从2000年1月至2005年12月,在华盛顿医院中心,有294例依赖透析的患者接受了独立的CABG治疗。其中168例行OPCAB(非泵组),126例行心肺搭桥术(CPB)的CABG(泵上组)。分析了院内结局。结果:两组在术前特征方面具有可比性。泵组的Parsonnet床边评分与泵组的相似(32.0 vs. 32.0,P = .57)。非泵组的院内死亡率显着低于泵上组(5.4%vs. 11.9%,P = .04)。尽管接受输血的患者百分比相似,但泵上组接受了更多的总输血。 Logistic回归分析显示,使用CPB可以独立预测院内死亡率[比值比(OR)为5.0; 95%置信区间1.78-13.85; P <.01]和围手术期心肌梗死(MI; OR,5.1; 95%置信区间,1.18-22.40; P = .03)。两组医院幸存者在4年时的长期存活率方面无显着差异。结论:我们的数据表明,在透析患者中​​,OPCAB是泵上CABG的安全替代品。避免使用CPB会减少围手术期血液利用率,心肌梗死和医院死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号